| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Molecular Immunology, Scripps Clinic and Research Foundation, La Jolla, California, The Department of Pediatrics, National Jewish Hospital, Denver, Colorado and The Department of Dermatology, Veteran's Administration Hospital, La Jolla, California
Abstract
Peptides C3a and C5a, also known as anaphylatoxins, are derived from C components C3 and C5 and have previously been reported to exhibit chemotactic activity. Virtually no data exist, however, regarding the relative potency of C3a or C5a for stimulating directed cellular movement. The chemotactic response of polymorphonuclear leukocytes (PMN) toward purified human C3a and C5a was determined under both in vitro and simulated in vivo conditions. Leukotactic activity of human C5a and C3a was examined with a modified Boyden chamber assay over a broad concentration range. Human C5a exhibited activity only over the range of 0.04 to 1.7 x 10-8 M. Greater or lesser concentrations of C5a were incapable of stimulating cellular migration. Since C5a is rapidly converted to C5ades Arg by a carboxypeptidase in serum, we also examined this modified anaphylatoxin molecule. For this study C5aArg was formed by digesting C5a with pancreatic carboxypeptidase B (EC 3.4.2.2). Human C5ades Arg is a form of C5a that is inactive as an anaphylatoxin. C5ades Arg was active as a chemotactic factor in the in vitro assay, but only when nonactivated serum was added. Approximately 10 times more C5ades Arg than C5a is required to stimulate a leukotactic response and the magnitude of the maximum cellular response is only about 50% of that produced by intact C5a. It was observed that serum provides a definite helper role for C5ades Arg stimulated chemotaxis under the in vitro assay procedures employed. Human C3a was inactive over a concentration range from 8 x 10-10 to 8 x 10-6 M and trypsintreated human C3 was also active over a range of 4 x 10-8 to 2.4 x 10-6 M. Earlier reports that 1- to 5-min trypsin digestion of C3 generates a chemotactic activity were not confirmed by our studies with human PMN; however, previous observations of activity may have resulted from minor contamination of the C3 with C5.
Human C5a was maximally active over a narrow concentration range of 2 to 6 x 10-7 M as estimated in rabbits by utilizing a skin window assay technique (Otani and Hugli, 1977). Human C5ades Arg also stimulated neutrophil accumulation under simulated in vivo conditions but at a slightly higher concentration range of 0.2 to 1.2 x 10-6 M. The C5ades Arg did not require added serum to produce an apparent leukotactic response in vivo, but, as in vitro, activity was not observed at levels above or below the effective concentration ranges indicated for C5a and C5ades Arg C3a was inactive over a concentration range of 5.5 x 10-9 to 5.5 x 10-6 M as an attractant for rabbit neutrophils in the skin window assay. The concentrations of C5a or C5ades Arg that are required to induce chemotaxis under simulated in vivo conditions correspond to the potential serum levels of these factors (e.g., 4 to 5 x 10-7 M). It is suggested from our quantitative measurements that the predominant chemotactic activity generated in human serum during C activation is associated with the C5ades Arg molecule. Therefore, C5ades Arg exhibits the potential for playing a predominant functional role under physiologic conditions as a major humoral chemotactic factor.
Footnotes
1 This work was supported by United States Public Health Service Grant HL 20220, a Program Project Grant from the National Heart and Lung Institute, HL 16411, and Grant-in-Aid 74-864 from the American Heart Association, Inc. This is publication Number 1359 from Scripps Clinic and Research Foundation.
2 Dr. Hugli is the recipient of an Established Investigatorship (72–175) from the American Heart Association, Inc.
This article has been cited by other articles:
|
|
 |
|
  S. Chatterjee, O. Lardinois, M. G. Bonini, S. Bhattacharjee, K. Stadler, J. Corbett, L. J. Deterding, K. B. Tomer, M. Kadiiska, and R. P. Mason Site-Specific Carboxypeptidase B1 Tyrosine Nitration and Pathophysiological Implications following Its Physical Association with Nitric Oxide Synthase-3 in Experimental Sepsis J. Immunol., September 15, 2009; 183(6): 4055 - 4066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Rollins Where the Confusion Began: Cloning the First Chemokine Receptors J. Immunol., September 1, 2009; 183(5): 2893 - 2894. [Full Text] [PDF]
|
|
|
|
|
|
I. U. Schraufstatter, R. G. DiScipio, M. Zhao, and S. K. Khaldoyanidi C3a and C5a Are Chemotactic Factors for Human Mesenchymal Stem Cells, Which Cause Prolonged ERK1/2 Phosphorylation J. Immunol., March 15, 2009; 182(6): 3827 - 3836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nitta, T. Imamura, Y. Wada, A. Irie, H. Kobayashi, K. Okamoto, and H. Baba Production of C5a by ASP, a Serine Protease Released from Aeromonas sobria J. Immunol., September 1, 2008; 181(5): 3602 - 3608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oda, K. Tokita, Y. Ota, Y. Li, K. Taniguchi, N. Nishino, K. Takagi, T. Yamamoto, and H. Nishiura Agonistic and Antagonistic Effects of C5a-Chimera Bearing S19 Ribosomal Protein Tail Portion on the C5a Receptor of Monocytes and Neutrophils, Respectively J. Biochem., September 1, 2008; 144(3): 371 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boor, A. Konieczny, L. Villa, A.-L. Schult, E. Bucher, S. Rong, U. Kunter, C. R.C. van Roeyen, T. Polakowski, H. Hawlisch, et al. Complement C5 Mediates Experimental Tubulointerstitial Fibrosis J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1508 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Waters, R. M. Brodbeck, J. Steflik, J. Yu, C. Baltazar, A. E. Peck, D. Severance, L. Y. Zhang, K. Currie, B. L. Chenard, et al. Molecular Characterization of the Gerbil C5a Receptor and Identification of a Transmembrane Domain V Amino Acid That Is Crucial for Small Molecule Antagonist Interaction J. Biol. Chem., December 9, 2005; 280(49): 40617 - 40623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Zabel, S. J. Allen, P. Kulig, J. A. Allen, J. Cichy, T. M. Handel, and E. C. Butcher Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades J. Biol. Chem., October 14, 2005; 280(41): 34661 - 34666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Trujillo and R. R. Kew Platelet-Derived Thrombospondin-1 Is Necessary for the Vitamin D-Binding Protein (Gc-Globulin) to Function as a Chemotactic Cofactor for C5a J. Immunol., September 15, 2004; 173(6): 4130 - 4136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shrestha, L. Shi, S. Tanase, M. Tsukamoto, N. Nishino, K. Tokita, and T. Yamamoto Bacterial Chaperone Protein, Skp, Induces Leukocyte Chemotaxis via C5a Receptor Am. J. Pathol., March 1, 2004; 164(3): 763 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Weerth, H. Rus, M. L. Shin, and C. S. Raine Complement C5 in Experimental Autoimmune Encephalomyelitis (EAE) Facilitates Remyelination and Prevents Gliosis Am. J. Pathol., September 1, 2003; 163(3): 1069 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shrestha, M. Shiokawa, T. Nishimura, H. Nishiura, Y. Tanaka, N. Nishino, Y. Shibuya, and T. Yamamoto Switch Moiety in Agonist/Antagonist Dual Effect of S19 Ribosomal Protein Dimer on Leukocyte Chemotactic C5a Receptor Am. J. Pathol., April 1, 2003; 162(4): 1381 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. U. Schraufstatter, K. Trieu, L. Sikora, P. Sriramarao, and R. DiScipio Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells J. Immunol., August 15, 2002; 169(4): 2102 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Yuan, M. H. Wu, E. E. Ustinova, M. Guo, J. H. Tinsley, P. de Lanerolle, and W. Xu Myosin Light Chain Phosphorylation in Neutrophil-Stimulated Coronary Microvascular Leakage Circ. Res., June 14, 2002; 90(11): 1214 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dobrina, M. Pausa, F. Fischetti, R. Bulla, E. Vecile, E. Ferrero, A. Mantovani, and F. Tedesco Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo Blood, January 1, 2002; 99(1): 185 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shibuya, M. Shiokawa, H. Nishiura, T. Nishimura, N. Nishino, H. Okabe, K. Takagi, and T. Yamamoto Identification of Receptor-Binding Sites of Monocyte Chemotactic S19 Ribosomal Protein Dimer Am. J. Pathol., December 1, 2001; 159(6): 2293 - 2301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.P. Crocker, N. Lawson, P.N. Baker, and J. Fletcher The anti-inflammatory effects of circulating fatty acids in obstructive jaundice: similarities with pregnancy-induced immunosuppression QJM, September 1, 2001; 94(9): 475 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Speth, G. Stöckl, I. Mohsenipour, R. Würzner, H. Stoiber, C. Lass-Flörl, and M. P. Dierich Human Immunodeficiency Virus Type 1 Induces Expression of Complement Factors in Human Astrocytes J. Virol., March 15, 2001; 75(6): 2604 - 2615. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. DiMartino, A. B. Shah, G. Trujillo, and R. R. Kew Elastase Controls the Binding of the Vitamin D-Binding Protein (Gc-Globulin) to Neutrophils: A Potential Role in the Regulation of C5a Co-Chemotactic Activity J. Immunol., February 15, 2001; 166(4): 2688 - 2694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Meddows-Taylor, L. Kuhn, T. M. Meyers, G. Sherman, and C. T. Tiemessen Defective Neutrophil Degranulation Induced by Interleukin-8 and Complement 5a and Down-Regulation of Associated Receptors in Children Vertically Infected with Human Immunodeficiency Virus Type 1 Clin. Vaccine Immunol., January 1, 2001; 8(1): 21 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Bohnsack, S. Takahashi, L. Hammitt, D. V. Miller, A. A. Aly, and E. E. Adderson Genetic Polymorphisms of Group B Streptococcus scpB Alter Functional Activity of a Cell-Associated Peptidase That Inactivates C5a Infect. Immun., September 1, 2000; 68(9): 5018 - 5025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I P Crocker, P N Baker, and J Fletcher Neutrophil function in pregnancy and rheumatoid arthritis Ann Rheum Dis, July 1, 2000; 59(7): 555 - 564. [Abstract] [Full Text]
|
|
|
|
|
|
B. TÜZÜN, Y. TÜZÜN, C. MAT, S. YURDAKUL, V. HAMURYUDAN, H. YAZICI, and Y. ÖZYAZGAN Neuropsychiatric systemic lupus erythematosus. Ann Rheum Dis, October 1, 1999; 58(10): 658 - 659. [Full Text]
|
|
|
|
|
|
J. Barlic, M. H. Khandaker, E. Mahon, J. Andrews, M. E. DeVries, G. B. Mitchell, R. Rahimpour, C. M. Tan, S. S. G. Ferguson, and D. J. Kelvin beta -Arrestins Regulate Interleukin-8-induced CXCR1 Internalization J. Biol. Chem., June 4, 1999; 274(23): 16287 - 16294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ottonello, A. Corcione, G. Tortolina, I. Airoldi, E. Albesiano, A. Favre, R. D'Agostino, F. Malavasi, V. Pistoia, and F. Dallegri rC5a Directs the In Vitro Migration of Human Memory and Naive Tonsillar B Lymphocytes: Implications for B Cell Trafficking in Secondary Lymphoid Tissues J. Immunol., June 1, 1999; 162(11): 6510 - 6517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nataf, N. Davoust, R. S. Ames, and S. R. Barnum Human T Cells Express the C5a Receptor and Are Chemoattracted to C5a J. Immunol., April 1, 1999; 162(7): 4018 - 4023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. DiScipio, P. J. Daffern, M. A. Jagels, D. H. Broide, and P. Sriramarao A Comparison of C3a and C5a-Mediated Stable Adhesion of Rolling Eosinophils in Postcapillary Venules and Transendothelial Migration In Vitro and In Vivo J. Immunol., January 15, 1999; 162(2): 1127 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, J. Loy, R.-P. Ryseck, D. Carrasco, and R. Bravo Antigen-Induced Eosinophilic Lung Inflammation Develops in Mice Deficient in Chemokine Eotaxin Blood, November 15, 1998; 92(10): 3912 - 3923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Pellas, W. Boyar, J. van Oostrum, J. Wasvary, L. R. Fryer, G. Pastor, M. Sills, A. Braunwalder, D. R. Yarwood, R. Kramer, et al. Novel C5a Receptor Antagonists Regulate Neutrophil Functions In Vitro and In Vivo J. Immunol., June 1, 1998; 160(11): 5616 - 5621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Huang, D. S. Friend, W.-T. Qiu, G. W. Wong, G. Morales, J. Hunt, and R. L. Stevens Induction of a Selective and Persistent Extravasation of Neutrophils into the Peritoneal Cavity by Tryptase Mouse Mast Cell Protease 6 J. Immunol., February 15, 1998; 160(4): 1910 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-z. Shang, B. J. Lang, and A. C. Issekutz Adhesion Molecule Mechanisms Mediating Monocyte Migration Through Synovial Fibroblast and Endothelium Barriers: Role for CD11/CD18, Very Late Antigen-4 (CD49d/CD29), Very Late Antigen-5 (CD49e/CD29), and Vascular Cell Adhesion Molecule-1 (CD106) J. Immunol., January 1, 1998; 160(1): 467 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C K Ameho, A A Adjei, E K Harrison, K Takeshita, T Morioka, Y Arakaki, E Ito, I Suzuki, A D Kulkarni, A Kawajiri, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis Gut, October 1, 1997; 41(4): 487 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Berge, B.-M. Kihlberg, A. G. Sjoholm, and L. Bjorck Streptococcal Protein H Forms Soluble Complement-activating Complexes with IgG, but Inhibits Complement Activation by IgG-coated Targets J. Biol. Chem., August 15, 1997; 272(33): 20774 - 20781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Forssmann, M. Uguccioni, P. Loetscher, C. A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes J. Exp. Med., June 16, 1997; 185(12): 2171 - 2176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hartmann, B. M. Henz, S. Kruger-Krasagakes, J. Kohl, R. Burger, S. Guhl, I. Haase, U. Lippert, and T. Zuberbier C3a and C5a Stimulate Chemotaxis of Human Mast Cells Blood, April 15, 1997; 89(8): 2863 - 2870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nishiura, Y. Shibuya, S. Matsubara, S. Tanase, T. Kambara, and T. Yamamoto Monocyte Chemotactic Factor in Rheumatoid Arthritis Synovial Tissue J. Biol. Chem., January 12, 1996; 271(2): 878 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Lepidi, Y Zaffran, J. Ansaldi, J. Mege, and C Capo Morphological polarization of human polymorphonuclear leucocytes in response to three different chemoattractants: an effector response independent of calcium rise and tyrosine kinases J. Cell Sci., January 4, 1995; 108(4): 1771 - 1778. [Abstract] [PDF]
|
|
|
|
 |
|
 D. S. Kucukaksu, S. F. Katircioglu, G. Saydam, M. Bozdayi, B. Mavitas, O. Tasdemir, and K. Bayazit Beneficial Effects of Prostacyclin on Pulmonary Function During Heparin Reversal with Protamine Vascular and Endovascular Surgery, May 1, 1993; 27(4): 264 - 267. [Abstract] [PDF]
|
|
|
|
 |
|
 R. I. Lehrer, T. Ganz, M. E. Selsted, B. M. Babior, and J. T. Curnutte Neutrophils and Host Defense Ann Intern Med, July 15, 1988; 109(2): 127 - 142. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Bengtson, G. K. Hansson, and M. Heideman In Vivo Determination of Modulated Migration of Radiolabeled Leukocytes Arch Surg, August 1, 1987; 122(8): 909 - 912. [Abstract] [PDF]
|
|
|
|
 |
|
 L. L Mickleborough, G. Arnold, and R. C-J Chiu Complement consumption during cardiopulmonary bypass: bubble versus membrane oxygenators Perfusion, October 1, 1986; 1(4): 261 - 269. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Ben-Zvi, M. M. Rodrigues, I. Gery, and E. Schiffmann Induction of Ocular Inflammation by Synthetic Mediators Arch Ophthalmol, August 1, 1981; 99(8): 1436 - 1444. [Abstract] [PDF]
|
|
|
|
|
|
J. I. GALLIN, D. G. WRIGHT, H. L. MALECH, J. M. DAVIS, M. S. KLEMPNER, and C. H. KIRKPATRICK Disorders of Phagocyte Chemotaxis Ann Intern Med, April 1, 1980; 92(4): 520 - 538. [Abstract] [PDF]
|
|
|
|
|
|
J. P. LEDDY and R. T. STEIGBIGEL Complement, Serum Bactericidal Activity, and Disseminated Gram-Negative Infection Ann Intern Med, June 1, 1979; 90(6): 984 - 985. [Abstract] [PDF]
|
|
|
|
 |
|
 T. L. Ray and K. D. Wuepper Experimental Cutaneous Candidiasis in Rodents-Reply Arch Dermatol, January 1, 1979; 115(1): 107 - 108. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
